Cargando…

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study

BACKGROUND: Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debellut, Frédéric, Clark, Andrew, Pecenka, Clint, Tate, Jacqueline, Baral, Ranju, Sanderson, Colin, Parashar, Umesh, Kallen, Laura, Atherly, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024955/ https://www.ncbi.nlm.nih.gov/pubmed/31708147 http://dx.doi.org/10.1016/S2214-109X(19)30439-5

Ejemplares similares

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
por: Pecenka, Clint, et al.
Publicado: (2017)

Estimating the global impact of rotavirus vaccines on child mortality
por: Clark, Andrew, et al.
Publicado: (2023)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines
por: Pecenka, Clint, et al.
Publicado: (2018)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2022)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2018)

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
por: Debellut, Frédéric, et al.
Publicado: (2022)

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Cost-effectiveness analysis for rotavirus vaccine decision-making: How can we best inform evolving and complex choices in vaccine product selection?
por: Pecenka, Clint, et al.
Publicado: (2020)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
por: Hausdorff, William P., et al.
Publicado: (2022)

Removing the Age Restrictions for Rotavirus Vaccination: A Benefit-Risk Modeling Analysis
por: Patel, Manish M., et al.
Publicado: (2012)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
por: Baral, Ranju, et al.
Publicado: (2021)

Economic evaluation of rotavirus vaccination in children of Bhutan
por: Pempa, et al.
Publicado: (2020)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Cost-effectiveness of rotavirus vaccination in Mozambique
por: Lourenço Guimarães, Esperança, et al.
Publicado: (2022)

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data
por: Bar-Zeev, Naor, et al.
Publicado: (2016)

Global rotavirus vaccine introductions and coverage: 2006 – 2016
por: Abou-Nader, Alice J., et al.
Publicado: (2018)

Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031
por: Nonvignon, Justice, et al.
Publicado: (2018)

Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC
por: Debellut, Frédéric, et al.
Publicado: (2020)

Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials
por: Clark, Andrew, et al.
Publicado: (2019)

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
por: Baral, Ranju, et al.
Publicado: (2020)

The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
por: Glass, Roger I, et al.
Publicado: (2021)

Global Experience With Rotavirus Vaccines
por: Burke, Rachel M, et al.
Publicado: (2021)

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness
por: Owusu, Richmond, et al.
Publicado: (2023)

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
por: Birger, Ruthie, et al.
Publicado: (2022)

Current and new rotavirus vaccines
por: Burke, Rachel M., et al.
Publicado: (2019)

93. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination: the United States, 2000–2018
por: Hallowell, Benjamin D, et al.
Publicado: (2019)

Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination
por: Clark, Andrew D, et al.
Publicado: (2019)

Trends in the Burden and Seasonality of Rotavirus in the United States, 2000–2016
por: Aliabadi, Negar, et al.
Publicado: (2017)

Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination — United States, 2000–2018
por: Hallowell, Benjamin D., et al.
Publicado: (2019)

Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries
por: Debellut, Frédéric, et al.
Publicado: (2018)

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

1170. Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review And Meta-analysis
por: Cates, Jordan, et al.
Publicado: (2021)

Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uah9ef7qnb1rknjoll5eokv70n